About this Journal Submit a Manuscript Table of Contents

Extracorporeal Therapies in the Intensive Care Unit

Call for Papers

The ability to support common organ system failures, in particular ventilatory, circulatory, renal, and liver failure, is a hallmark of intensive care. Artificial ventilation and dialysis are common treatments in the ICU. More sophisticated technologies such as extracorporeal membrane oxygenation (ECMO) for respiratory and/or cardiac failure or liver support with albumin dialysis are also increasingly used. New physiological data as well as technological progress have led to new indications. For example, full lung support may be assured with ECMO in cases of refractory hypoxemia. On the other hand, miniaturized devices using low blood flow are now available and allow ultraprotective ventilation and could be used for other indications such as COPD decompensation in order to avoid intubation. 

In this current issue, we are particularly interested in receiving manuscripts reporting research articles, clinical studies, or review articles dealing with extracorporeal therapies in the ICU.

Potential topics include, but are not limited to:

  • Hemofiltration
  • Hemodialysis
  • Plasmapheresis
  • ECMO
  • ECCO 2R
  • Albumin dialysis
  • Artificial liver
  • Charcoal column for poisoning
  • Hemoperfusion with a polymyxin B membrane
Manuscript DueFriday, 10 October 2014
First Round of ReviewsFriday, 2 January 2015
Publication DateFriday, 27 February 2015

Lead Guest Editor

  • Bruno Levy, Institut du Coeur et des Vaisseaux, Vandoeuvre les Nancy, France

Guest Editors

  • Alain Combes, Université Pierre et Marie Curie, Paris, France
  • Julia A. Wendon, Institute of Liver Studies, London, UK
  • Claudio Ronco, The International Renal Research Institute (IRRIV), Vicenza, Italy